Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation
- 98 Downloads
RET codon 609 point mutations are rare and may predispose to aggressive medullary thyroid carcinoma (MTC). In a kindred with 15 carriers of the Cys609Ser RET mutation we observed no MTC before 17 years of age, no lymph node metastases before 30 years and no distant metastases before 60 years. Two patients developed pheochromocytoma and one had primary hyperparathyroidism as the first sign of the syndrome. In conclusion, at variance from what already known, in this large kindred the Cys609Ser RET mutation predispose to a scarcely aggressive, highly penetrant MTC and a low penetrance of pheochromocytoma and primary hyperparathyroidism.
KeywordsRET MEN2A Medullary thyroid carcinoma Pheochromocytoma
This study was supported by a grant from Ministero dell’Istruzione, Università e Ricerca No200734RMKE-002 (2008–2009 to C.M.) and PRIN 2006060473_003 (to G.O.). We also thank Mrs. Frances Anne Coburn for text editing.
- 3.Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671. doi: 10.1210/jc.86.12.5658 CrossRefPubMedGoogle Scholar
- 5.Patocs A, Klein I, Szilvasi A, Gergics P, Toth M, Valkusz Z, Forizs E, Igaz P, Al-Farhat Y, Tordai A, Varadi A, Racz K, Esik O (2006) Genotype–phenotype correlations in Hungarian patients with hereditary medullarythyroid cancer. Wien Klin Wochenschr 118:417–421. doi: 10.1007/s00508-006-0635-9 CrossRefPubMedGoogle Scholar
- 7.Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW (2005) Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Horumon To Rinsho 63:676–682Google Scholar
- 10.Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H, Takahashi M (1999) Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene 18:3919–3922. doi: 10.1038/sj.onc.1202742 CrossRefPubMedGoogle Scholar